𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Severe infections in plasmapheresis-treated systemic lupus erythematosus

✍ Scribed by Martin Aringer; Josef S. Smolen; Winfried B. Graninger

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
820 KB
Volume
41
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Severe neutropenia in systemic lupus ery
Severe neutropenia in systemic lupus erythematosus
✍ Peter Gergely πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

## 719 by steroid pulse in our patient appeared more consistent, and might explain in part the medium-to long-term efficiency of such treatments. These results also suggest that sequential studies might prove useful to assess the possible efficiency of a pulse, as well as to determine the best pro

Incidence of infection in systemic lupus
Incidence of infection in systemic lupus erythematosus
✍ Parker J. Staples; Dale N. Gerding; Dr. John L. Decker; Robert S. Gordon Jr. πŸ“‚ Article πŸ“… 1974 πŸ› John Wiley and Sons 🌐 English βš– 655 KB

## Abstract Twenty‐three patients with systemic lupus erythematosus (SLE), 20 with rheumatoid arthritis (RA), and 11 with the nephrotic syndrome (NPS) were selected for study of factors affecting the incidence of infection in these diseases. The overall infection rate (infections per 100 hospital d

Infection in patients with systemic lupu
Infection in patients with systemic lupus erythematosus
✍ H Daniel Perez; Richard I Andron; Ira M Goldstein πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 673 KB

## Abstract We have found subnormal amounts of chemotactic activity in zymosan‐treated sera from 13 of 29 patients with systemic lupus erythematosus (SLE). As an explanation for this abnormality, the presence of a uniquely specific, heat‐stable inhibitor of complement (C5)‐derived chemotactic activ